VIP Vial Size — Dosing, Storage & Reconstitution

VIP Vial Size — Dosing, Storage & Reconstitution

A 5mg VIP vial size doesn't mean each injection delivers 5mg. Yet that's the single most common miscalculation researchers make when working with vasoactive intestinal peptide for the first time. The vial size describes the total lyophilized peptide mass before reconstitution, not the concentration per dose. Without converting vial mass to solution concentration based on your chosen bacteriostatic water volume, dosing precision becomes impossible. The difference between therapeutic effect and wasted compound comes down to understanding the relationship between VIP vial size, reconstitution volume, and final peptide concentration.

We've guided hundreds of researchers through peptide reconstitution protocols across immune function studies, neuroprotection research, and inflammatory pathway investigation. The gap between doing it right and wasting an expensive compound comes down to three things most guides never mention: calculating concentration correctly, maintaining cold chain integrity, and understanding the stability window post-reconstitution.

What is VIP vial size and how does it affect dosing calculations?

VIP vial size refers to the total mass of lyophilized vasoactive intestinal peptide powder contained in a single sealed vial before reconstitution. Typically available in 2mg, 5mg, or 10mg configurations. Dosing accuracy depends entirely on dividing this total mass by the volume of bacteriostatic water added during reconstitution to determine the final concentration in mcg/mL. A 5mg VIP vial size reconstituted with 5mL bacteriostatic water yields 1000mcg/mL (1mg/mL), while the same vial mixed with 10mL yields 500mcg/mL. A twofold concentration difference that directly impacts every subsequent dose drawn from that vial.

Yes, VIP vial size directly determines concentration once you add bacteriostatic water. But the mechanism most people misunderstand is the volume-to-mass ratio. The vial label states total peptide mass (5mg VIP vial size, for example), not concentration. You create the concentration through reconstitution. One common error: assuming a smaller reconstitution volume makes dosing easier. It doesn't. It makes errors larger. A 5mg vial mixed with 2mL bacteriostatic water creates a 2500mcg/mL solution where each 0.1mL contains 250mcg, and measurement precision at that concentration requires syringes graduated to 0.01mL. This article covers VIP vial size specifications across supplier inventories, the mathematics of concentration calculation, storage requirements that prevent degradation, and reconstitution protocols that maintain peptide integrity throughout the research timeline.

VIP Vial Size Configurations Across Research Suppliers

VIP vial size availability follows three standard configurations: 2mg, 5mg, and 10mg lyophilized powder. These sizes reflect synthesis batch economics rather than biological dosing rationale. Larger vial sizes reduce per-milligram cost but require researchers to maintain strict cold chain storage for longer durations once reconstituted. A 2mg VIP vial size supports approximately 20–40 administrations at typical research doses (50–100mcg per injection), while a 10mg vial extends that to 100–200 administrations depending on study protocol. The tradeoff is stability: reconstituted VIP maintains potency for 28 days refrigerated at 2–8°C, meaning a 10mg vial used at 50mcg per dose twice weekly would remain viable for the full stability window, but a single-use study would waste 98% of the peptide.

Real Peptides supplies VIP in precise vial size configurations verified through HPLC (high-performance liquid chromatography) to confirm stated peptide mass. Every batch undergoes amino acid sequencing to guarantee the 28-residue structure of vasoactive intestinal peptide remains intact. This matters because partial sequences or degraded peptides may reconstitute and appear visually identical to intact VIP but deliver no receptor activity. The distinction between a 5mg VIP vial size labeled through estimation versus one verified through spectroscopy can represent the difference between reproducible results and unexplained variability across study cohorts.

Vial size selection depends on research timeline and dose frequency. A 2mg VIP vial size suits pilot studies or single-subject investigation where the peptide will be fully consumed within two weeks post-reconstitution. A 5mg configuration balances cost efficiency with reduced waste for studies running 4–8 weeks with dosing two to three times per week. The 10mg VIP vial size becomes cost-effective only in high-frequency protocols or multi-subject studies where the entire vial contents will be used before the 28-day refrigerated stability window closes. Ordering a larger vial to reduce per-milligram cost but discarding 60% of the reconstituted solution negates any economic advantage.

Storage requirements differ pre- and post-reconstitution. Unreconstituted VIP in lyophilized form remains stable at −20°C for 12–24 months depending on supplier specifications. Once reconstituted with bacteriostatic water, VIP must be refrigerated at 2–8°C and used within 28 days. This timeline reflects peptide bond hydrolysis and oxidative degradation, not bacterial contamination (bacteriostatic water prevents microbial growth). Temperature excursions above 8°C accelerate degradation exponentially: a single 24-hour period at room temperature can reduce peptide activity by 15–30%, and neither visual inspection nor pH measurement can detect this loss. The only reliable indicator is loss of expected biological effect in the assay.

Reconstitution Math: Converting VIP Vial Size to Concentration

The most critical calculation in peptide research is converting VIP vial size into final solution concentration based on bacteriostatic water volume. The formula: (total peptide mass in mcg) ÷ (bacteriostatic water volume in mL) = concentration in mcg/mL. A 5mg VIP vial size equals 5000mcg total mass. Add 5mL bacteriostatic water: 5000mcg ÷ 5mL = 1000mcg/mL. Add 10mL instead: 5000mcg ÷ 10mL = 500mcg/mL. Every dose drawn from the vial depends on this baseline concentration. Miscalculate here and every subsequent injection delivers the wrong dose.

Dosing precision requires matching syringe graduation to concentration. At 1000mcg/mL concentration (5mg vial in 5mL water), a 50mcg dose requires drawing 0.05mL. Standard insulin syringes graduate to 0.01mL, providing adequate precision. At 2500mcg/mL concentration (5mg vial in 2mL water), that same 50mcg dose requires drawing 0.02mL. Now you're operating at the lower limit of insulin syringe precision, and measurement error compounds across multiple doses. Concentration is not arbitrary. It must align with your measurement tools. Higher concentrations reduce injection volume but increase dosing error; lower concentrations improve measurement precision but require larger injection volumes that may exceed subcutaneous injection comfort thresholds.

Consider a research protocol requiring 100mcg VIP per administration, dosed three times per week, across an eight-week study. Total peptide needed: 100mcg × 3 doses/week × 8 weeks = 2400mcg = 2.4mg. A 2mg VIP vial size falls short; a 5mg vial provides adequate supply with buffer for dosing error or extended timeline. Reconstitute the 5mg vial with 10mL bacteriostatic water to achieve 500mcg/mL concentration. Each 100mcg dose requires drawing 0.2mL. Easily measured with standard insulin syringes. This protocol consumes 2.4mg of the 5mg total, leaving 2.6mg remaining at the 28-day stability limit. Acceptable waste margin.

Reconstitution technique affects peptide integrity. Inject bacteriostatic water slowly down the inside wall of the vial, never directly onto the lyophilized peptide cake. Direct impact can denature protein structure. Allow the water to dissolve the peptide passively through diffusion; do not shake or vortex. Gentle swirling is acceptable once 80% of the powder has dissolved. Complete dissolution typically takes 3–5 minutes at room temperature. If particulates remain after 10 minutes, refrigerate the vial for 30 minutes and swirl again. Forcing dissolution through agitation risks aggregation, where peptide molecules clump into inactive complexes.

VIP Vial Size and Storage Protocol to Prevent Degradation

VIP vial size does not alter storage requirements, but it does change the risk profile. A 10mg VIP vial size reconstituted for a low-dose study will spend weeks in refrigerated storage, and every day increases cumulative exposure to degradation pathways: oxidation of methionine residues, deamidation of asparagine and glutamine, and peptide bond hydrolysis. These processes occur even under ideal refrigeration. Cold slows degradation but does not stop it. A 2mg vial consumed within one week faces minimal degradation risk; a 10mg vial used over four weeks loses 5–10% potency by the final dose even when stored correctly.

Unreconstituted lyophilized VIP must be stored at −20°C in a freezer with minimal temperature fluctuation. Frost-free freezers cycle temperature to prevent ice buildup, causing repeated freeze-thaw stress that degrades peptides over months. A manual-defrost freezer or a laboratory-grade unit with tight temperature control is ideal. Light exposure degrades VIP through photooxidation. Store vials in the original amber glass or wrap in aluminum foil. Once removed from −20°C storage for reconstitution, do not return the vial to the freezer. Reconstituted peptides must never be refrozen.

Reconstituted VIP requires refrigeration at 2–8°C immediately after mixing. Standard refrigerator temperatures in the 4–6°C range are acceptable, but the vial must not freeze (which can occur in the back of some refrigerators where temperatures drop below 2°C) and must not be stored in the door (where temperature fluctuates with every opening). Place the vial in the main compartment, away from the cooling element. Each time you draw a dose, allow the vial to warm to room temperature for 2–3 minutes before injecting air into it. Injecting cold air into a cold vial creates condensation inside the vial that introduces moisture and accelerates degradation.

Bacteriostatic water contains 0.9% benzyl alcohol as a preservative, preventing bacterial growth in multi-dose vials. This allows a reconstituted VIP vial to remain sterile across multiple needle punctures over 28 days. Sterile water lacks this preservative and supports bacterial growth once the vial is punctured. Never use sterile water for multi-dose reconstitution. Some researchers use sodium chloride 0.9% (saline) for reconstitution, which is isotonic and reduces injection site irritation, but standard saline lacks bacteriostatic properties unless specifically labeled as bacteriostatic saline. Real Peptides offers Bacteriostatic Water as a separate product to ensure researchers have pharmaceutical-grade reconstitution solution that maintains peptide stability and sterility throughout the use window.

VIP Vial Size Comparison: Cost Efficiency vs Research Timeline

Cost per milligram decreases as VIP vial size increases, but actual cost efficiency depends on utilization rate. A 10mg vial purchased at $8/mg ($80 total) appears more economical than a 2mg vial at $12/mg ($24 total), but if your protocol uses only 3mg before the 28-day window closes, you discard $56 worth of peptide. The effective cost becomes $80 ÷ 3mg = $26.67/mg, more than double the 2mg vial price. Calculate effective cost as (total vial price) ÷ (mg actually used), not listed price per mg.

Research timeline constraints often override cost considerations. An eight-week study dosing 100mcg three times per week requires 2400mcg total. A 2mg vial is insufficient; a 5mg vial provides adequate coverage with minimal waste. Ordering a 10mg vial to reduce per-milligram cost leaves 7.6mg unused. Unless you have concurrent studies that can consume the excess within the same 28-day window, the cost savings evaporate. The 5mg VIP vial size represents the optimal balance for most research applications: sufficient supply for standard study durations without excessive waste.

Some researchers attempt to extend stability beyond 28 days by aliquoting reconstituted VIP into single-dose syringes and freezing them at −20°C. This approach introduces two risks: (1) freeze-thaw stress degrades peptides even when frozen once, and (2) syringe plastics can adsorb peptides from solution, reducing effective concentration by 10–25% depending on contact time and plastic type. If extended storage is required, aliquot into sterile glass vials with rubber stoppers instead of plastic syringes, and accept that potency will decline 15–20% over three months even when frozen. Fresh reconstitution from a new lyophilized vial always outperforms extended frozen storage.

Key Takeaways

• VIP vial size indicates total lyophilized peptide mass before reconstitution, not dose per injection. Concentration is determined by the volume of bacteriostatic water added during mixing.
• A 5mg VIP vial size reconstituted with 10mL bacteriostatic water yields 500mcg/mL concentration, requiring a 0.1mL draw for a 50mcg dose. Match syringe precision to concentration to prevent dosing errors.
• Unreconstituted lyophilized VIP remains stable for 12–24 months at −20°C, but once reconstituted it must be refrigerated at 2–8°C and used within 28 days as peptide bonds degrade even under refrigeration.
• Larger vial sizes reduce cost per milligram but only achieve cost efficiency if the full peptide mass is consumed before the 28-day post-reconstitution stability window expires.
• Bacteriostatic water containing 0.9% benzyl alcohol is required for multi-dose vials to prevent bacterial contamination across repeated needle punctures. Sterile water lacks preservative and supports microbial growth.
• Temperature excursions above 8°C cause irreversible peptide denaturation that visual inspection cannot detect. Cold chain integrity from supplier to storage to reconstitution is non-negotiable.

What If: VIP Vial Size Scenarios

What If I Reconstitute a 5mg VIP Vial with Too Much or Too Little Water?

Recalculate your dose volume based on actual concentration. If you intended 5mL but added 7mL by error, your concentration is now 5000mcg ÷ 7mL = 714mcg/mL instead of 1000mcg/mL. A 50mcg dose now requires drawing 0.07mL instead of 0.05mL. The peptide is not ruined. The math just changed. Adding too little water (e.g., 3mL instead of 5mL) creates 1667mcg/mL concentration where a 50mcg dose is only 0.03mL, pushing measurement precision to the limits of standard syringes. Document the actual volume added and adjust all subsequent doses accordingly rather than discarding the vial.

What If My VIP Vial Was Left at Room Temperature Overnight After Reconstitution?

Assume 15–30% potency loss and increase your dose proportionally if research timeline permits, or discard and reconstitute a fresh vial if precision is critical. Peptide degradation from temperature excursion is irreversible. Refrigerating the vial afterward does not restore lost activity. For a study requiring exact dose reproducibility across subjects, a compromised vial introduces uncontrolled variability. For preliminary dose-finding studies, you can continue using the vial with dose adjustment, but note the incident in your protocol documentation.

What If I Need to Use a 10mg VIP Vial Size But My Study Only Requires 3mg Total?

Reconstitute only if you have concurrent studies that will consume the remaining 7mg within 28 days, or accept the waste as unavoidable. Alternatively, plan a follow-up study phase that begins before the stability window closes. Some labs coordinate shared vial use across multiple researchers working on related protocols. If your institution supports this, a 10mg vial split between two concurrent studies eliminates waste. Never reconstitute a large vial